Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. - Wikidata - awgldk - TriplyDB

Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.

Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.

http://www.wikidata.org/entity/Q45259870

about

Budesonide for induction of remission in Crohn's disease Budesonide for maintenance of remission in Crohn's disease Budesonide for maintenance of remission in Crohn's disease Budesonide for induction of remission in Crohn's disease Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials Therapeutic benefits of budesonide in gastroenterology Therapeutic challenges of managing inflammatory bowel disease in the elderly patient.Osteoporosis in inflammatory bowel disease Collagenous enterocolitis and maturity onset type 1 diabetes manifesting as uraemia, malabsorption and extreme weight loss.Budesonide in the treatment of inflammatory bowel disease.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Therapy insight: Osteoporosis in inflammatory bowel disease--advances and retreats.Managing complicated Crohn's disease in children and adolescents.Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.Principles and strategies for monitoring home parenteral nutrition.Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease.The immune response in inflammatory bowel disease.Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.Treatment of inflammatory bowel disease: a review of medical therapy.Guidelines for the management of growth failure in childhood inflammatory bowel disease.Budesonide for Crohn's disease.Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis What is the optimal therapy for Crohn's disease: step-up or top-down?Nutritional considerations in pediatric inflammatory bowel disease.Glucocorticoid-induced osteoporosis in men.Inflammatory bowel disease of the elderly: frequently asked questions (FAQs).Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?Steroid use in Crohn's disease.Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.MMX® technology and its applications in gastrointestinal diseases.Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL).Clinical relevance of changes in bone metabolism in inflammatory bowel disease.Manipulating bone disease in inflammatory bowel disease patients.Endocrine and metabolic manifestations in inflammatory bowel disease Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.Crohn’s disease: Advise and consent.Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.

P2860

Q24187309-4E878A19-E8C9-4F43-9F6E-081183B476A8 Q24194313-D4639A73-528D-4E1A-A1AF-5409B2C1600B Q24241252-44EEAC8C-80AF-4AC0-8B38-4DFCC63C2CB7 Q24242729-84FDEA72-85CF-4A94-830F-4D1F7844E875 Q26779042-69433E00-7B13-4BF9-9187-E5E7CC86A75B Q28266279-8E5AF466-A084-4144-AE8F-0A6BA2C02791 Q28281682-879A12A3-17BB-4A16-8281-54EE17178685 Q30251570-E73FEA35-179F-4154-A1EB-DE754C08BE74 Q33951441-3FF26E2D-3699-4C77-B7EB-C97670DEFE7B Q33955999-32363182-FE7E-402E-A18B-1A8AF3AC3B12 Q34203594-3BE9EA39-A0B9-4311-82A2-57DC9A139F93 Q34564902-CDC42AB4-8B6D-48C0-8C57-471B7A06EB72 Q36304133-B8A85ABB-62CC-496E-83F7-4915E9646370 Q36331225-870B7565-371F-43F2-8986-2FF42BE62EDF Q36659176-16BB7D67-7AD2-4843-B1EE-D7BC48B812D7 Q36824466-1016C24D-C25C-49A1-98EB-A74696B3D528 Q36844709-DDC21995-FA56-49AB-B262-3EF3C9E2DEF6 Q36846736-917A453D-238C-4F48-988A-34A1D1681F5C Q36919671-8B44C53E-08B5-44FF-A68A-C0FD0DCA5329 Q37058862-0E0DB976-4D0D-4084-913B-866865459307 Q37081554-F07C6FCC-C5FE-4AF5-A272-BE3A4F2B7A9E Q37554383-9031C44E-8361-45DE-A221-5B3056A83EDF Q37577773-FBFD9A37-1D12-4E75-B465-6F37B018ED10 Q37720746-6EFC0B74-760F-410F-9CA8-AF7F98037148 Q37763081-6DFBE905-4559-4A04-AE17-99C5AD000D25 Q37881839-FD63B9B4-2F3A-440B-8827-62E828D3813E Q37921606-F6B19CAB-5C6B-47B6-B9C3-5F63183EE7B7 Q38026396-EF90A556-5A3A-4142-A70C-334CCE21E6B4 Q38188477-B210E16B-AA0E-4FE8-869A-188EA09E6BB4 Q38216510-4D5E5C9E-CA2D-461F-95D4-7D279E0F81CD Q38726458-36D31E77-801A-457D-920D-25B94FDB6287 Q40046590-A46338A3-5333-482D-B578-3B5C70F9882A Q40095211-2F27FD86-5672-4F23-B19F-D3E02A8F700F Q41692244-C9DDA6C4-4724-4D54-BB62-DD3D0EF03904 Q42342936-97AAD68A-D450-4E45-B84F-76A2B11C1500 Q42406589-F531D266-3A38-4C40-A689-576519D75935 Q42406756-CC521A19-538A-4740-88F4-540BD48C3F50 Q45937561-F5C6B849-DBA9-46AF-AC7D-BFCF2DEFED22 Q46484666-0196FE33-E6A0-44F7-ADFD-AC844B5C3745 Q46787148-28C5AB7B-AE71-49BA-8167-EE8D99DFE3DE

P2860

Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.

http://www.wikidata.org/entity/Q45259870

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@en

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@nl

type

label

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@en

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@nl

prefLabel

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@en

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@nl

P1433

Q45259870-0C83BF39-02EB-4B2D-BE99-FF047AA34418

P1476

Q45259870-24762654-2CFB-4CE6-835E-6E122A75D10D

P2093

Q45259870-01C0AFDA-7E83-4828-9758-EBDE70D390E7

Q45259870-0D7BC9CC-9C0F-4B2A-BD91-8D8358105A7E

Q45259870-0E8538DD-2DB7-43D4-AA8F-C01D921319FB

Q45259870-199CF83E-ED24-4885-83F4-621F2290B091

Q45259870-59707E40-C3C0-4672-BDF7-907B30B23B47

Q45259870-5F62918F-5B08-4633-B9DE-841DD040DF60

Q45259870-932FCC7D-692C-4F35-9CBC-2E097D4AD043

Q45259870-9B01E261-12F5-4A9B-9D93-0BF852E66D2B

Q45259870-A785742C-0A0C-4476-B079-35E9BBF1C121

Q45259870-C26D02CA-187D-4492-BCFB-C7BFFC4684FA

P304

Q45259870-4F235779-763F-47AC-8046-4BB7CC1B2ADF

P31

Q45259870-043C3C36-3D4E-425A-A153-EB5E0EDD30DF

P356

Q45259870-C0101DC2-EBE1-4E75-871C-A1B13C6750AC

P407

Q45259870-00955367-680E-4780-BDA8-50BABF0447EC

P433

Q45259870-28E48A6C-852D-4422-8140-EBD7895822DC

P478

Q45259870-C63BDF97-5CD3-4C45-8DED-85C5AD508AC7

P577

Q45259870-299DC495-584E-44F7-BDB2-6C15CAFFAC97

P698

Q45259870-B534EC14-1EFE-4B9D-80DA-4972E5F67861

P356

S1542-3565(04)00662-7

P1433

Clinical Gastroenterology and Hepatology

P1476

Bone mineral density in relati ...... ednisolone in Crohn's disease.

@en

P2093

Dieter Felsenberg

http://www.w3.org/2001/XMLSchema#string

Eran Israeli

http://www.w3.org/2001/XMLSchema#string

Erik J Schoon

http://www.w3.org/2001/XMLSchema#string

Gabriele Bianchi Porro

http://www.w3.org/2001/XMLSchema#string

Hans Graffner

http://www.w3.org/2001/XMLSchema#string

Louise Haptén-White

http://www.w3.org/2001/XMLSchema#string

Matrix Study Group

http://www.w3.org/2001/XMLSchema#string

Morten Vatn

http://www.w3.org/2001/XMLSchema#string

Peter R Mills

http://www.w3.org/2001/XMLSchema#string

Reinhold W Stockbrügger

http://www.w3.org/2001/XMLSchema#string

P304

113-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1542-3565(04)00662-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15704045

http://www.w3.org/2001/XMLSchema#string